Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)

https://www.globenewswire.com/news-release/2021/11/05/2328440/0/en/Zealand-Pharma-and-DEKA-Research-Development-Corp-Announce-Collaboration-Agreement-to-Advance-Development-of-Infusion-Pump-to-Be-Used-with-Dasiglucagon-for-Treatment-of-Congenital-.html

press release